Acute Lymphoblastic Leukemia: Optimizing MRD Testing
0 Views
administrator
06/15/23
Mark R. Litzow, MD; Anthony S. Stein, MD; Aaron C. Logan, MD, PhD; and Bijal D. Shah, MD, reflect on the optimal time to test for minimal residual disease and how to best interpret the results regarding the prognosis of a patient with acute lymphoblastic leukemia.
-
Category
Show more
Facebook Comments
No comments found